The Israel Precision Medicine Partnership – IPMP
Promotes innovative biomedical research in Israel leading to a deeper understanding of human biology and mechanisms of disease and the development of novel treatment and diagnostic approaches.
About IPMP
Recent Projects
NEW
Nano Code – Finding the Right Drug for Treating Cancer Using Nano-Particles in a Patient
NEW
Defining Sensitivity and Overcoming Resistance to PARP Inhibition in Pancreatic Ductal Adenocarcinoma Using Combined Genomics and Metabolomics Tools
NEW
Inherited Retinal Diseases: From the Identification of Genes and Risk Factors to a New Method of Personalized Medicine
NEW
Immunotherapy of Glioblastoma with Metabolically Superior Bi-Specific CAR T-Cells
NEW
Dynamic Risk Prediction Model for Post-Trauma Psychopathology, Based on Multi-Scale and Multi-Layered Profiling of Stress Response
NEW
Elucidating Epigenetic Mechanisms that Drive Autism Spectrum Disorder and Tailoring a Personalized Treatment
NEW
Modeling Tubulopathies Using Patient-Specific Kidney Organoids for Renal Precision Medicine – Mitochondrial Disease-Associated Fanconi Syndrome as Proof of Concept
NEW
Personalizing Multiple Myeloma Prognosis and Treatment: Advanced Single-Cell Genomics Analysis of the Dynamics of Tumor-Immune Crosstalk
NEW
Overcoming Resistance to CAR-T Cell Therapy due to Antigen Loss or Modulation by New Chimeric Receptors Targeting Intracellular-Derived HLA Peptidome
 
NEW
The Delivery Mechanism of Tumor-Derived Extracellular Vesicles
NEW
Understanding the Relation of Cellular and Immuno-senescence in Aging and their Relevance to the Dynamics and Clinical Outcomes of Severe Infections
NEW
A Computational and Experimental Personalized Medicine Approach for the Diagnosis and Treatment of Rare Genetic Diseases
NEW
Personalized Risk Assessment of Colorectal Cancer Based on Natural Anti-Cancer Defense Mechanisms: A Potential Tool for Prevention and Early Detection
NEW
Towards Precision Therapy in Infectious Diseases – Personalizing Bacteriophage and Antibiotic Treatments
NEW
Genetic and Epigenetic Modifiers of Disease Phenotypes – Skin Diseases as a Paradigm
NEW
A Personalized 3D Oxygen-Sensing Skin Graft for the Diagnosis and Treatment of Chronic Wounds in Patients with Diabetes
Our principles
IPMP - advancing innovative and
groundbreaking biomedical
research in Israel
Data Sharing
An essential component of the program is
the rapid deposition of the research data
into databases that are shared with the
scientific community.An essential component of the program is that organizations participating in IPMP research projects must be committed to providing open and equitable access to their medical and clinical data, and to rapidly depositing the data from their projects in accessible databases, in accordance with IPMP terms based on best practice globally.
This will include information obtained within the program (such as genomic and somatic sequences) and data collected but not published (such as genomic sequences).
The confidentiality of study participants will be ensured.
The collaborative data sharing between researchers in universities, hospitals and healthcare organizations will help accelerate the rate of discoveries and the potential for implementing new healthcare protocols. It will also significantly advance Israeli research capabilities.
Biomedical Networking
The IPMP will encourage biomedical networking – an emerging area of research dealing with molecular and genetic interactions, biomarkers of disease and discovery of therapeutic targets.
Researchers will assess how the results of biomedical networking, aided by phenotype-specific biomedical data, can be most effectively applied to research project goals.
The IPMP will encourage biomedical networking – an emerging area of research dealing with molecular and genetic interactions, biomarkers of disease and discovery of therapeutic targets.
Researchers will assess how the results of biomedical networking, aided by phenotype-specific biomedical data, can be most effectively applied to research project goals.
Multidisciplinary Research
An essential feature of the IPMP program is to encourage and facilitate comprehensive, large-scale projects between researchers in multiple biomedical and computational fields.
The program will enable Israeli researchers to conduct groundbreaking projects in fields of human health that depend substantially on collaboration between researchers in institutions of higher education and healthcare organizations, utilizing the big data stored on Israeli hospital and HMO databases, and engaging with communities of both sick and healthy volunteers. This exciting new venture will expand Israeli scientific horizons and achievements.
 
Summary of IPMP
43
%
of the applicants are physicians and clinical researchers from hospitals
14
research proposals were selected for funding in the first cycle
17
universities, hospitals and HMOs are collaborating in the approved projects of the first cycle
210000000
overall IPMP budget: about NIS 210 million